Endocrine Abstracts

Teriparatide is a skeletal anabolic drug that represents the first and new class of bone anabolic agents able to increase bone formation, bone mineral density and strength. Several studies demonstrated the efficacy of this drug in post-menopausal and glucocorticoid-induced osteoporosis, but few data are available on the effects of the drug in long-term therapy in humans, so far.We analyzed a population of 135 women in post-menopausal age treated with ter...